Top St. Louis, MO Biotech Companies (30)
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm.
Tansna Therapeutics is a developer of an oral anticonvulsant agent that reduces seizure frequency in patients with epilepsy.
APT Therapeutics is a Biotechnology company located in 4041 Forest Park Ave., St. Louis, MO, United States.
Mobius Therapeutics is an early-stage venture focused on ophthalmic surgery solutions.
Readout is a sensor biomarker startup that enables sustained metabolic optimization of patients and self-care consumers with fat oxidation biofeedback in breath. We introduced Biosense in 2020 as a Class 1 medical device for in-home behavior modification. Our digital experience allows "dosing" of ketosis with a patented deep lung sampling technology in a precision nutrition journey from weight loss to healthspan in the palm of your hands.
DNA Polymerase Technology develops technology for detecting, analyzing and manipulating genes.
BioSTL builds regional capacity and fosters collaborative efforts to advance innovation,
As of September 2014, G-Biosciences management system governing the manufacture of our products is ISO9001:2008 certified. For more details on G-Biosciences biotechnology and life science research products click the products tab. Geno Technology, Inc. was founded in 1994 with a vision to simplify life science research. Our primary goal was to target the key techniques of protein research and find affordable methods to simplify and improve on these techniques. Over the years Geno Technology, Inc. has branched out into other areas of research, but our primary target still remains with proteins and our primary goal “simplify and improve on these techniques” still holds true. This message was reinforced in 2010 with the evolution of “The Protein Man”, our iconic mascot and the G-Biosciences brand. G-Biosciences’ team examined every aspect of particular experimental techniques, ranging from protein extraction to protein purification and detection, to identify key areas that we could target for improvement. As a result of this we now manufacture everything from simple buffers at convenient concentrations and sizes to custom manufactured devices, such as Tube-O-Dialyzer, that enhance and simplify key techniques. Our key areas we focused on included, but not limited to, protein assays, sample preparation, electrophoresis, Western blotting, mass spectrometry, assay development, antibody production and protein purification. G-Biosciences now offers thousands of products for the protein and life science research market, all designed with the hope of make a researcher’s lab time simpler and more affordable. Geno Biosciences Pvt. Ltd. is a division of Geno Technology, Inc. based in New Dehli, India. G-Biosciences, India is engaged in the distribution of the products manufactured by the parent company. Most recently supplementing G-Biosciences products with other leading manufacturers products to enhance the G-Biosciences inventory.
GreenLight Biosciences is a mission-driven public-benefit corporation using the power of RNA to tackle some of humanity's greatest challenges, including pandemics, rare diseases, biodiversity and climate change.
Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense™ test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn
Ensign-Bickford Industries, Inc. (EBI), founded in 1836, is a privately-owned high technology conglomerate focused in space & defense, pet food science, and biotechnology. We participate in businesses that are relevant to the future of the world and have multigenerational growth prospects. EBI companies are unified by a common shared operating system and a common set of values.
Wugen is a developer of a novel CAR-T therapy platform intended for T-Cell Malignancies.
Digital health company with holographic AR platform for intraprocedural clinical use.
Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.
Tioma Therapeutics is a venture-stage biopharmaceutical company.
PierianDx is catalyzing global adoption of genomic sequencing in healthcare
Confluence is a contract research organization providing mechanistic enzymology, target validation, characterization, and more.
OpenCell Technologies provides efficient, high-throughput and scalable transfection tools to researchers in the Life Sciences.
Intuitive Genomics helps customers to quickly uncover the vital insights and actionable information they need from their massive
EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders.
Work Your Passion. Live Your Purpose.
